The Blueprint Medicines Corp brand, founded in 2000 (United States), from 2951 sister brands and 17477 competing brands. Blueprint Medicines Corp is owned by NOVARTIS N, listed on the stock exchange of Zurich The International Securities Identification Number (ISIN) of NOVARTIS N is CH0012005267. Blueprint Medicines Corp is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
NOVARTIS N
(Blueprint Medicines Corp)
over 5 years*
CHF 99.43